---
title: "FINE STUART A — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6ee05c25-e549-538c-8e29-eb66a494f7d8
json: https://whiteintel.dev/api/public/dossier/6ee05c25-e549-538c-8e29-eb66a494f7d8
identifier: sec:0001312681
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# FINE STUART A

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001312681`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6ee05c25-e549-538c-8e29-eb66a494f7d8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6ee05c25-e549-538c-8e29-eb66a494f7d8  

## Ownership & control

### Holdings / subsidiaries

- **AKESIS PHARMACEUTICALS, INC.** (other) — https://whiteintel.dev/entity/96d69bd9-b0e5-509e-ada6-985ed0bd25ff

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **FINE STUART A**. Human view: https://whiteintel.dev/entity/6ee05c25-e549-538c-8e29-eb66a494f7d8 · Structured JSON: https://whiteintel.dev/api/public/dossier/6ee05c25-e549-538c-8e29-eb66a494f7d8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._